Medikinet

Methylphenidate Hydrochloride, the active ingredient in Medikinet, is a central nervous system stimulant presented as an oral formulation for oral use. It is prescribed for the management of attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults, helping to improve concentration and reduce excessive daytime sleepiness.

GNH USA supplies Medikinet as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets globally.

Medikinet (methylphenidate) is used in central nervous system stimulant therapy for neurobehavioral disorders.

- Attention deficit hyperactivity disorder (ADHD): improves focus, reduces hyperactivity and impulsivity. - Adult ADHD: enhances work performance and daily functioning. - Narcolepsy: decreases excessive daytime sleepiness and sudden sleep attacks.

Common Side Effects: - Insomnia: difficulty falling or staying asleep. - Decreased appetite: reduced hunger leading to weight loss. - Headache: mild to moderate cranial pain. - Stomach pain: abdominal discomfort or cramps.

Serious or Rare Side Effects: - Cardiovascular events: hypertension, tachycardia, or arrhythmia. - Psychosis: emergence of hallucinations or delusional thoughts. - Severe allergic reaction: rash, swelling, or breathing difficulty.

Before initiating therapy, consider the following precautions. - Cardiovascular assessment: evaluate heart history and blood pressure. - Psychiatric monitoring: watch for new or worsening mood or psychotic symptoms. - Growth monitoring: regularly track height and weight in children. - Abuse potential: use only as prescribed and store securely. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Methylphenidate may interact with several drug classes.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Tricyclic antidepressants: may increase cardiovascular side effects. - Antihypertensive agents: may reduce blood pressure‑lowering efficacy.

Moderate Interactions (Monitor Closely):\n- CYP2D6 inhibitors (e.g., fluoxetine): may raise methylphenidate plasma levels. - Antacids: can affect gastrointestinal absorption. - Alcohol: may enhance central nervous system stimulation.